Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 27 Sept 2019 for Novelion Therapeutics Inc., €2,987. Read the official filing
Filing timeline
BuySaleBarbara Chan
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Barbara Chan: trading record in brief
All filings by Barbara Chan on record concern Novelion Therapeutics Inc. We count 7 filings; the first trade dates from 29 November 2016 and the latest from 24 September 2019.
Every open-market trade on record is a sale: 1 sale worth €2,696. Other entries cover 3 option exercises.
Most recently, on 27 September 2019, the filings show an option exercise worth €2,987 in Novelion Therapeutics Inc. Filings reach the SEDI feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to Barbara Chan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,733 shares@ CA$0.7677.3% of flowCommon SharesTSXSEDI:3429814
1,688 shares@ CA$0.7622.7% of flowCommon SharesTSXSEDI:3429828
1,871 shares@ CA$1.2625.0% of flowCommon SharesTSXSEDI:3339107
996 shares@ CA$1.2613.3% of flowCommon SharesTSXSEDI:3339110
1,216 shares@ CA$3.33Common SharesTSXSEDI:3096509
3,750 sharesCommon SharesTSXSEDI:3096508
Common SharesTSXSEDI:3096507
7 of 7 declarations
